For sure , both Maraviroc and Ibalizumab very low
Post# of 145247
I am just very surprise that many posters don't give enough attention to those numbers and side effects ..
To me , globally I don't consider any drug as a serious competition to our Leronlimab for drug resistant HIV at this time .
.
And there are many patients with resistance , globally , in many countries much higher % than in USA..
IMO.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)